RedHill Biopharma, a Tel Aviv-listed healthcare company backed by mutual fund manager Fidelity’s corporate venturing unit, has dual-floated on the Nasdaq stock exchange.
In November 2010, RedHill Biopharma, an Israel-based biopharmaceutical company started the year before, raised more than $10m from a consortium including mutual fund manager Fidelity Investments’ Biosciences venture capital (VC) team.